Aripiprazole Tablet
Product Images NDC 50090-6409

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 50090-6409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure9 (Aripiprazole Fig9)

FDA Label Image

Figure4 (Aripiprazole Fig4)

FDA Label Image

Figure5 (Aripiprazole Fig5)

FDA Label Image

Figure6 (Aripiprazole Figure6)

This is a graph or chart showing the proportion with R and the number of subjects at risk over a period of days from randomization. The data is broken down into different categories based on a number of subjects at risk.*

FDA Label Image

Figure7 (Aripiprazole Figure7)

FDA Label Image

Figure8 (Aripiprazole Figure8)

FDA Label Image

Structure (Aripiprazole Struct)

FDA Label Image

Aripiprazole_fig_01 (Aripiprazole Fig 01)

FDA Label Image

Aripiprazole_fig_02 (Aripiprazole Fig 02)

This is a table showing the effect of various drugs on Aripiprazole, specifically how they affect its fold change relative to a reference (without interacting drugs). The drugs listed include Keloconazole as a CYP1A2 inhibitor, Quinidine as a CYP2D6 inhibitor, Carbamzspine as a CYP1M inducer, and various Gastric Acid Blockers. No further information is available.*

FDA Label Image

Aripiprazole_fig_03 (Aripiprazole Fig 03)

FDA Label Image

Label Image (Lbl500906409)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.